FDA approves weight-loss drug Qsymia
Overweight individuals will soon have a new weapon in the struggle to lose pounds. Medically supervised weight-loss clinics were awaiting the decision this month on the new weight-loss drug originally called Qnexa, now Qsymia.
The FDA previously declined Qsymia for full approval to treat obesity. Qsymia is a combination of two drugs that currently have a limited role in treating obesity, Phentermine and Topiramate. Phentermine is an appetite ...